Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

A Nanopatterned Interdigitated Electrode Array Device for Anti-migratory Cancer Drug Screening

Award Number: R43CA221659
ORGANIZATION: NATIONAL CANCER INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/21/2017
PERIOD OF PERFORMANCE END DATE: 06/20/2018

Group Awards By:

View Award Description

A Nanopatterned Interdigitated Electrode Array Device for Anti-migratory Cancer Drug Screening - PROJECT SUMMARY As the cancer drug industry suffers from the lowest success rate in developing cancer-cure drugs, cell migration assessment assays that evaluate the transition of cells from a benign to a metastatic phenotype have gained more attention. Given the fact that metastatic cancer cells are substantially harder to eradicate than those that are benign, migratory propensity is now understood to be a key metric in both assessing cell migration behavior and screening anti-migratory compounds. However, conventional cell migration assays suffer from high cost of equipment, labor-intensive procedures and non-biomimetic culture environment. In addition, high-throughput, real-time quantification of collective cell migration requires live-cell microscopic monitoring that requires expensive microscope systems and fluorescent cell labeling for automatic tracking. Also, most conventional cell migration assays are performed on flat culture surfaces which lack topographical or mechanical cues necessary to provoke a metastatic phenotype and induce fast, directed collective cell migration observed during in vivo metastasis. The proposed cell migration assay platform incorporating anisotropic nanopatterned polymer substrates provides a more robust alternative to chemotactic systems. Enhanced biomimicry in this culture environment will enhance response sensitivity of the migrating cancer tissues in presence of test compounds, yielding a more predictive assay. In this proposed platform, we propose to integrate unique ion-permeable nanotopographic polymer substrates with a label free, impedance-based interdigitated electrode array (IEA) biosensor for detecting real-time quantification of collective cell migration in a high-throughput manner. We hypothesize that changes in IEA impedance magnitude can be reproducibly correlated to the migration distance, enabling real-time calculation of migratory velocity of the collective cell cultures. We further predict that such a relationship will permit the evaluation of dynamic, nanotopographically- guided tissue responses to anti-migratory agents. Finally, we anticipate that, aided by the proposed platform's biomimetic nanotopography, this system will significantly outperform prior art in its predictive capacity in evaluating cell migration kinetics. To test these hypotheses, single and multi-well unpatterned and nanopatterned IEA sensors will be fabricated and integrated with a simple, custom-made impedance analyzer. Reproducible correlations will be established between collective cellular migration distance and sensor impedance. Once this correlation is established, the IEA sensor will be used to test a series of pharmaceutical compounds through cellular migration assays. Lastly, nanopatterned culture data obtained through this project will be compared to scientific literature data to further evaluate the predictive utility of the proposed nanoIEA platform. Successful validation of this nanoIEA system will clear the way for the commercialization of a product that stands to advance the efficacy of preclinical cancer drug screening, thereby significantly leading to streamlined drug development.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2019 ( Subtotal = $0 )
2019	2017	NANOSURFACE BIOMEDICAL, INC.	4000 MASON RD STE 304	SEATTLE	WA	98195	KING	USA	Cancer Treatment Research	000	1	12/4/2018	NEW	$0
														Subtotal = $0

Issue Date FY: 2017 ( Subtotal = $225,000 )
2017	2017	NANOSURFACE BIOMEDICAL, INC.	4000 MASON RD STE 304	SEATTLE	WA	98195	KING	USA	Cancer Treatment Research	000	1	9/21/2017	NEW	$225,000
														Subtotal = $225,000

Grand Total All Awards = $225,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

A Nanopatterned Interdigitated Electrode Array Device for Anti-migratory Cancer Drug Screening

Award Number: R43CA221659

ORGANIZATION: NATIONAL CANCER INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/21/2017

PERIOD OF PERFORMANCE END DATE: 06/20/2018

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer